DE | EN

Nils Koppers

Current affiliations

Humangenetik, Abt. für Genetische Epidemiologie

Publications

Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound Janoschka C; Lindner M; Koppers N; Starost L; Liebmann M; Eschborn M; Schneider-Hohendorf T; Windener F; Schafflick D; Fleck AK; Koch K; Deffner M; Schwarze AS; Schulte-Mecklenbeck A; Metz I; Gross CC; Meuth SG; Schwab N; Meyer Zu Hörste G; Wiendl H; Kuhlmann T; Klotz L; Stoll M (2023) In: Proceedings of the National Academy of Sciences of the United States of America, 120(1) Type of Publication: Research article (journal)
Studies in Zebrafish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E2 Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and Albuminuria Kourpa A, Schulz A, Mangelsen E, Kaiser-Grad D, Koppers N, Stoll M, Rothe M, Bader M, Purfürst B, Kunz S, Gladytz T, Niendorf T, Bachmann S, Mutig K, Bolbrinker J, Panakova D, Kreutz R (2023) In: Journal of Hypertension, 80(4) Type of Publication: Research article (journal)
Studies in Zebrafish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E-2 Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and Albuminuria Kourpa, Aikaterini; Schulz, Angela; Mangelsen, Eva; Kaiser-Graf, Debora; Koppers, Nils; Stoll, Monika; Rothe, Michael; Bader, Michael; Purfuerst, Bettina; Kunz, Severine; Gladytz, Thomas; Niendorf, Thoralf; Bachmann, Sebastian; Mutig, Kerim; Bolbrinker, Juliane; Panakova, Daniela; Kreutz, Reinhold (2023) In: Hypertension, 80(4) Type of Publication: Research article (journal)